Schedule 13G ownership disclosure

MEREO BIOPHARMA GROUP PLC

Security class unavailable · CUSIP: 589492107

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
6,899,669
Percent of class
6.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000899140-21-000350
Form type
SC 13G
Filer
Mereo BioPharma Group plc
CIK
CIK 1719714
Filed
Mar 01, 2021
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub